Maso Capital Partners Ltd lifted its holdings in shares of iKang Healthcare Group, Inc. (NASDAQ:KANG) by 8.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,504,062 shares of the medical research company’s stock after buying an additional 120,655 shares during the period. iKang Healthcare Group makes up 14.7% of Maso Capital Partners Ltd’s portfolio, making the stock its 2nd biggest position. Maso Capital Partners Ltd owned about 2.17% of iKang Healthcare Group worth $20,275,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in KANG. Pictet Asset Management Ltd. purchased a new stake in shares of iKang Healthcare Group during the third quarter valued at $330,000. SG Americas Securities LLC boosted its position in shares of iKang Healthcare Group by 14.6% during the second quarter. SG Americas Securities LLC now owns 44,608 shares of the medical research company’s stock valued at $547,000 after buying an additional 5,700 shares during the last quarter. FIL Ltd boosted its position in shares of iKang Healthcare Group by 45.4% during the second quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock valued at $4,429,000 after buying an additional 112,615 shares during the last quarter. Athos Capital Ltd purchased a new stake in shares of iKang Healthcare Group during the second quarter valued at $8,622,000. Finally, First Manhattan Co. boosted its position in shares of iKang Healthcare Group by 101.7% during the second quarter. First Manhattan Co. now owns 1,040,043 shares of the medical research company’s stock valued at $12,761,000 after buying an additional 524,318 shares during the last quarter. 33.11% of the stock is currently owned by institutional investors.

Separately, BidaskClub raised iKang Healthcare Group from a “sell” rating to a “hold” rating in a research report on Tuesday, August 15th.

iKang Healthcare Group, Inc. (KANG) opened at $14.64 on Wednesday. The company has a quick ratio of 0.76, a current ratio of 0.78 and a debt-to-equity ratio of 0.30. iKang Healthcare Group, Inc. has a 12-month low of $11.70 and a 12-month high of $18.41.

iKang Healthcare Group (NASDAQ:KANG) last announced its earnings results on Thursday, September 14th. The medical research company reported $0.06 earnings per share (EPS) for the quarter. The business had revenue of $115.60 million for the quarter. iKang Healthcare Group had a negative return on equity of 2.68% and a negative net margin of 2.16%.

ILLEGAL ACTIVITY WARNING: “Maso Capital Partners Ltd Grows Position in iKang Healthcare Group, Inc. (KANG)” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.watchlistnews.com/maso-capital-partners-ltd-grows-position-in-ikang-healthcare-group-inc-kang/1732260.html.

iKang Healthcare Group Profile

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Institutional Ownership by Quarter for iKang Healthcare Group (NASDAQ:KANG)

Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.